Ischemic stroke laboratory findings

Ischemic Stroke Microchapters
Main Stroke Page
Transient ischemic attack
Hemorrhagic Stroke Page
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Stroke from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
CT
MRI
Echocardiography
Ultrasound
Other Imaging Findings
Treatment
Early Assessment
Medical Therapy
Surgery
Rehabilitation
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
AHA/ASA Guidelines for Stroke
Case Studies
Case #1
Ischemic stroke laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Ischemic stroke laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Ischemic stroke laboratory findings
CDC on Ischemic stroke laboratory findings
Ischemic stroke laboratory findings in the news
Blogs on Ischemic stroke laboratory findings
Directions to Hospitals Treating Stroke
Risk calculators and risk factors for Ischemic stroke laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2]

Laboratory Findings

Labortary tests may help determine the risk factors complications of ischemic stroke. Blood tests which may be performed include:

Blood test	Test result	Rationale
Complete blood count	Leukocytosis and Thrombocytosis polycythemia thrombocytopenia,	May suggest underlying infection Increased risk of thrombotic event May increase the risk of bleeding in pateints eligible for thrombolytic therapy
Lipid profile	*Increased LDL, triglycerides and cholesterol	May increase the risk of thromboembolic event
PT/APTT/INR	Increased PT/APTT/INR	May increase the risk of bleeding in patients eligible for anticoagualant therapy May suggest underlying coagulation disorder
BUN/Creatinine	*Increased BUN and creatinine	Mild to moderate renal dysfunction is an independant risk factor for ischemic stroke May be associated with poor prognosis in patients with ischemic stroke
Serum homocysteine level	*Increased levels of serum homocysteine levels	May be associated with increased risk of thromboembolic event
Basic metabolic panel	*Increased or decreased serum NA2+, K+, Ca2+	May mimic or complicate patients with ischemic stroke
HbA1C	*Increased levels of HbA1c	May suggest control of diabetes in past few months Increased levels associated with increased risk of ischemic stroke May be associated with poor prognosis in patients with ischemic stroke
Blood glucose levels	*Increased or decreased levels of blood glucose	Hyperglycemia is associated with poor prognosis of ischemic stroke Hypoglycemia may complicate or mimic patients with ischemic stroke
*Cardiac enzymes	*Increased serum levels of Trop I, Trop T, CK-MB	May suggest ongoing myocardial ischemia
Pregnancy test	Serum and urine B-HCG	Rule out pregnancy in all female patients with ischemic stroke since t-PA is a class C agent

References

Template:WS Template:WH